Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali

NCT06413108 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

167

Enrollment

OTHER

Sponsor class

Conditions

Malaria,Falciparum

Interventions

DRUG: TB31F
OTHER: Normal saline

Sponsor

Radboud University Medical Center

Collaborators

Malaria Research and Training Center, Bamako, Mali
London School of Hygiene and Tropical Medicine